(S (NP (NP (NP (NNP Alzheimer) (POS 's)) (NNP Disease)) (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-)) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (DT a) (NN cascade)) (PP (IN of) (NP (NP (NP (NNS biomarkers)) (VP (VBG becoming) (ADJP (JJ abnormal)))) (, ,) (SBAR (WHNP (NP (DT the) (NN pathophysiology)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBZ is) (ADJP (ADJP (RB very) (JJ complex)) (CC and) (ADJP (RB largely) (JJ unknown)))))))))))) (. .))
(S (NP (ADJP (NN Event) (HYPH -) (VBN based)) (NN modeling) (PRN (-LRB- -LRB-) (NP (NN EBM)) (-RRB- -RRB-))) (VP (VBZ is) (NP (DT a) (ADJP (NN data) (HYPH -) (VBN driven)) (NN technique) (S (VP (TO to) (VP (VB estimate) (NP (NP (DT the) (NN sequence)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NNS biomarkers)) (PP (IN for) (NP (DT a) (NN disease)))) (VP (VBN become) (ADJP (JJ abnormal)) (PP (VBN based) (PP (IN on) (NP (JJ cross-sectional) (NNS data))))))))))))) (. .))
(S (NP (PRP It)) (VP (MD can) (VP (VP (VB help) (PP (IN in) (S (VP (VBG understanding) (NP (NP (DT the) (NNS dynamics)) (PP (IN of) (NP (NN disease) (NN progression)))))))) (CC and) (VP (VB facilitate) (NP (JJ early) (NN diagnosis) (CC and) (NN prognosis))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (NP (PRP we)) (VP (VBP propose) (NP (DT a) (JJ novel) (JJ discriminative) (NN approach)) (PP (IN to) (NP (NP (NNP EBM)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (RBR more) (JJ accurate) (PP (IN than) (NP (VBG existing) (ADJP (NN state) (HYPH -) (IN of) (HYPH -) (DT the) (HYPH -) (NN art)) (NN EBM) (NNS methods)))))))))))))) (. .))
(NP (NP (DT The) (NN method)) (NP (NP (JJ first) (NNS estimates)) (PP (IN for) (NP (DT each) (NN subject)))) (NP (NP (DT an) (JJ approximate) (NN ordering)) (PP (IN of) (NP (NNS events)))) (. .))
(S (ADVP (RB Subsequently)) (, ,) (NP (NP (DT the) (JJ central) (NN ordering)) (PP (IN over) (NP (DT all) (NNS subjects)))) (VP (VBZ is) (VP (VBN estimated) (PP (IN by) (S (VP (VBG fitting) (NP (NP (DT a) (VBN generalized) (NNPS Mallows)) (NP (NP (NN model)) (PP (IN to) (NP (DT these) (JJ approximate) (ADJP (NN subject) (HYPH -) (JJ specific)) (NNS orderings)))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBP introduce) (NP (NP (DT the) (NN concept)) (PP (IN of) (NP (NP (JJ relative) (NN distance)) (PP (IN between) (NP (NP (NNS events)) (SBAR (WHNP (WDT which)) (S (VP (VBZ helps) (PP (IN in) (S (VP (VBG creating) (NP (DT a) (NN disease) (NN progression) (NN timeline)))))))))))))) (. .))
(S (ADVP (RB Subsequently)) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (DT a) (NN method)) (S (VP (TO to) (VP (VB stage) (NP (NNS subjects)) (PP (IN by) (S (VP (VBG placing) (NP (PRP them)) (PP (IN on) (NP (DT the) (VBN estimated) (NN disease) (NN progression) (NN timeline)))))))))) (. .))
(S (NP (PRP We)) (VP (VBD evaluated) (NP (DT the) (JJ proposed) (NN method)) (PP (PP (IN on) (NP (NP (NNP Alzheimer) (POS 's)) (NML (NML (NNP Disease) (NNP Neuroimaging) (NNP Initiative)) (-LRB- -LRB-) (NML (NP (NNP ADNI))) (-RRB- -RRB-)) (NNS data))) (CC and) (PP (VBN compared) (NP (NP (DT the) (NNS results)) (PP (IN with) (NP (VBG existing) (ADJP (NN state) (HYPH -) (IN of) (HYPH -) (DT the) (HYPH -) (NN art)) (NN EBM) (NNS methods))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD performed) (NP (JJ extensive) (NNS experiments)) (PP (IN on) (NP (JJ synthetic) (NNS data))) (S (VP (VBG simulating) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (NP (NNP Alzheimer) (POS 's)) (NN disease))))))) (. .))
(S (NP (NP (DT The) (NN event) (NNS orderings)) (VP (VBN obtained) (PP (IN on) (NP (NN ADNI) (NNS data))))) (VP (VP (VBP seem) (ADJP (JJ plausible))) (CC and) (VP (VBP are) (PP (IN in) (NP (NP (NN agreement)) (PP (IN with) (NP (NP (DT the) (JJ current) (NN understanding)) (PP (IN of) (NP (NP (NN progression)) (PP (IN of) (NP (NN AD))))))))))) (. .))
(S (NP (DT The) (VBN proposed) (NML (NN patient) (NN staging)) (NN algorithm)) (VP (VBD performed) (ADJP (ADJP (RB consistently) (JJR better)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (NN EBM) (NNS methods))))))) (. .))
(S (S (NP (NP (NN Event) (NNS orderings)) (VP (VBN obtained) (PP (IN in) (NP (NN simulation) (NNS experiments))))) (VP (VBD were) (ADJP (ADJP (RBR more) (JJ accurate)) (PP (IN than) (NP (NP (DT those)) (PP (IN of) (NP (JJ other) (NN EBM) (NNS methods)))))))) (CC and) (S (NP (DT the) (VBN estimated) (NN disease) (NN progression) (NN timeline)) (VP (VBD was) (VP (VBN observed) (PP (IN to) (NP (NN correlate))) (PP (IN with) (NP (NP (DT the) (NN timeline)) (PP (IN of) (NP (JJ actual) (NN disease) (NN progression)))))))) (. .))
(S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT these) (NNS experiments)))) (VP (VP (VBP are) (VP (VBG encouraging))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ discriminative) (NN EBM)) (VP (VBZ is) (NP (NP (DT a) (JJ promising) (NN approach)) (PP (IN to) (NP (NN disease) (NN progression) (NN modeling))))))))) (. .))
